(Q54375107)

English

Cost effectiveness of crizotinib for anaplastic lymphoma kinase-positive, non-small-cell lung cancer: who is going to blink at the cost?

scientific article published on 24 February 2014

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24567437

retrieved

29 May 2018

reference URL

http://europepmc.org/abstract/MED/24567437

editorial

0 references

title

Cost effectiveness of crizotinib for anaplastic lymphoma kinase-positive, non-small-cell lung cancer: who is going to blink at the cost? (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24567437

retrieved

29 May 2018

reference URL

http://europepmc.org/abstract/MED/24567437

1 reference

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24567437

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24567437%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 June 2020

author name string

Ronan J Kelly

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24567437

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24567437%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 June 2020

Bruce E Hillner

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24567437

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24567437%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 June 2020

language of work or name

English

0 references

publication date

24 February 2014

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24567437

retrieved

29 May 2018

reference URL

http://europepmc.org/abstract/MED/24567437

published in

Journal of Clinical Oncology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24567437

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24567437%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 June 2020

volume

32

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24567437

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24567437%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 June 2020

issue

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24567437

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24567437%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 June 2020

page(s)

983-985

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24567437

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24567437%20AND%20SRC:MED&resulttype=core&format=json

(Q54375107)

Cost effectiveness of crizotinib for anaplastic lymphoma kinase-positive, non-small-cell lung cancer: who is going to blink at the cost?

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)